Hiroaki Nagano

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Marubashi Shigeru; Dono Keizo; Nagano Hiroaki; Kobayashi Shogo; Takeda Yutaka; Umeshita Koji; Monden Morito; Doki Yuichiro; Mori Masaki
Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture.
Noda Takehiro; Nagano Hiroaki; Miyamoto Atsushi; Wada Hiroshi; Murakami Masahiro; Kobayashi Shogo; Marubashi Shigeru; Takeda Yutaka; Dono Keizo; Umeshita Koji; Wakasa Kenichi; Monden Morito
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.
Tomimaru Yoshito; Nagano Hiroaki; Marubashi Shigeru; Kobayashi Shogo; Eguchi Hidetoshi; Takeda Yutaka; Tanemura Masahiro; Kitagawa Toru; Umeshita Koji; Hashimoto Nobuyuki; Yoshikawa Hideki; Wakasa Kenichi; Doki Yuichiro; Mori Masaki
Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hiroaki Nagano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Marubashi Shigeru; Dono Keizo; Nagano Hiroaki; Kobayashi Shogo; Takeda Yutaka; Umeshita Koji; Monden Morito; Doki Yuichiro; Mori Masaki
Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture.
Transplantation 2009;88(9):1123-30.
2009: Noda Takehiro; Nagano Hiroaki; Miyamoto Atsushi; Wada Hiroshi; Murakami Masahiro; Kobayashi Shogo; Marubashi Shigeru; Takeda Yutaka; Dono Keizo; Umeshita Koji; Wakasa Kenichi; Monden Morito
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.
International journal of clinical oncology / Japan Society of Clinical Oncology 2009;14(5):473-7.
2009: Tomimaru Yoshito; Nagano Hiroaki; Marubashi Shigeru; Kobayashi Shogo; Eguchi Hidetoshi; Takeda Yutaka; Tanemura Masahiro; Kitagawa Toru; Umeshita Koji; Hashimoto Nobuyuki; Yoshikawa Hideki; Wakasa Kenichi; Doki Yuichiro; Mori Masaki
Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.
World journal of gastroenterology : WJG 2009;15(33):4204-8.
2009: Akita H; Zheng Z; Takeda Y; Kim C; Kittaka N; Kobayashi S; Marubashi S; Takemasa I; Nagano H; Dono K; Nakamori S; Monden M; Mori M; Doki Y; Bepler G
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.
Oncogene 2009;28(32):2903-9.
2009: Shimoda Masafumi; Marubashi Shigeru; Dono Keizo; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Nagano Hiroaki; Hoshida Yoshihiko; Monden Morito
ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high.
Hepato-gastroenterology 2009;56(93):1174-7.
2009: Takemasa Ichiro; Ishii Hideshi; Haraguchi Naotsugu; Mimori Koshi; Tanaka Fumiaki; Nagano Hiroaki; Sekimoto Mitsugu; Doki Yuichiro; Mori Masaki
[Perspectives on current status and future directions for cancer stem cells theory in gastrointestinal cancer]
Nippon Geka Gakkai zasshi 2009;110(4):207-12.
2009: Noda T; Nagano H; Takemasa I; Yoshioka S; Murakami M; Wada H; Kobayashi S; Marubashi S; Takeda Y; Dono K; Umeshita K; Matsuura N; Matsubara K; Doki Y; Mori M; Monden M
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
British journal of cancer 2009;100(10):1647-58.
2009: Hama Naoki; Yanagisawa Yuka; Dono Keizo; Kobayashi Shogo; Marubashi Shigeru; Nagano Hiroaki; Umeshita Koji; Watanabe Shinya; Uchiyama Yasuo; Monden Morito
Gene expression profiling of acute cellular rejection in rat liver transplantation using DNA microarrays.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(5):509-21.
2009: Yoshioka Shinichi; Takemasa Ichiro; Nagano Hiroaki; Kittaka Nobuyoshi; Noda Takehiro; Wada Hiroshi; Kobayashi Shogo; Marubashi Shigeru; Takeda Yutaka; Umeshita Koji; Dono Keizo; Matsubara Kenichi; Monden Morito
Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 2009;45(5):881-9.
2009: Wada Hiroshi; Nagano Hiroaki; Yamamoto Hirofumi; Noda Takehiro; Murakami Masahiro; Kobayashi Shogo; Marubashi Shigeru; Eguchi Hidetoshi; Takeda Yutaka; Tanemura Masahiro; Umeshita Koji; Doki Yuichiro; Mori Masaki
Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.
BMC cancer 2009;9():361.
2008: Miyamoto Atsushi; Nagano Hiroaki; Doki Yuichiro; Nagata Yasuhiro; Kanematsu Takayuki; Monden Morito
[Questionnaire survey conducted by the Japan Surgical Society]
Nippon Geka Gakkai zasshi 2008;109(3):173-9.
2008: Kittaka Nobuyoshi; Takemasa Ichiro; Takeda Yutaka; Marubashi Shigeru; Nagano Hiroaki; Umeshita Koji; Dono Keizo; Matsubara Kenichi; Matsuura Nariaki; Monden Morito
Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
European journal of cancer (Oxford, England : 1990) 2008;44(6):885-97.
2008: Nakamura Masato; Nagano Hiroaki; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Kobayashi Shogo; Wada Hiroshi; Noda Takehiro; Dono Keizo; Umeshita Koji; Monden Morito
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
Cancer 2008;112(8):1765-71.
2008: Xu Xundi; Yamamoto Hirofumi; Liu Guoxing; Ito Yasuhiro; Ngan Chew Yee; Kondo Motoi; Nagano Hiroaki; Dono Keizo; Sekimoto Mitsugu; Monden Morito
CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
International journal of molecular medicine 2008;21(2):145-52.
2008: Nakahira Shin; Nakamori Shoji; Tsujie Masanori; Takeda Setsuo; Sugimoto Keishi; Takahashi Yuji; Okami Jiro; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.
Anticancer research 2008;28(1A):179-86.
2008: Akita Hirofumi; Hikita Hayato; Yamanouchi Eigoro; Marubashi Shigeru; Nagano Hiroaki; Umeshita Koji; Dono Keizo; Tsutsui Shusaku; Hayashi Norio; Monden Morito
Use of a metallic-wall stent in the magnet compression anastomosis technique for bile duct obstruction after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(1):118-20.
2007: Nagano Hiroaki; Miyamoto Atsushi; Wada Hiroshi; Ota Hideo; Marubashi Shigeru; Takeda Yutaka; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
Cancer 2007;110(11):2493-501.
2007: Uyama Hirokazu; Nagano Hiroaki; Nakamura Hideji; Murakami Takamichi; Nakamura Hironobu; Monden Morito; Hayashi Norio
New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of beta-interferon and doxorubicin one-shot intra-arterial chemotherapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(12):1018-25.
2007: Murakami Masahiro; Nagano Hiroaki; Noda Takehiro; Wada Hiroshi; Kobayashi Shogo; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshita Koji; Monden Morito
[A case of hepatocellular carcinoma with right atrium tumor thrombus treated with combined doxorubicin and interferon-beta/intra-arterial injection chemotherapy and hepatectomy]
Gan to kagaku ryoho. Cancer & chemotherapy 2007;34(12):2087-9.
2007: Noda Takehiro; Nagano Hiroaki; Murakami Masahiro; Kobayashi Shogo; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshita Koji; Wakasa Kenichi; Monden Morito
[Surgical treatment for peritoneal seeding and needle-tract implantation of hepatocellular carcinoma after ultrasound-guided percutaneous puncture]
Gan to kagaku ryoho. Cancer & chemotherapy 2007;34(12):2080-3.
2007: Marubashi Shigeru; Dono Keizo; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Monden Morito
Impact of graft size on postoperative thrombocytopenia in living donor liver transplant.
Archives of surgery (Chicago, Ill. : 1960) 2007;142(11):1054-8.
2007: Marubashi Shigeru; Dono Keizo; Nagano Hiroaki; Asaoka Tadafumi; Hama Naoki; Kobayashi Shogo; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Monden Morito
Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(11):1538-44.
2007: Wada Hiroshi; Nagano Hiroaki; Yamamoto Hirofumi; Arai Isao; Ota Hideo; Nakamura Masato; Damdinsuren Bazarragchaa; Noda Takehiro; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Doki Yuichiro; Dono Keizo; Nakamori Shoji; Sakon Masato; Monden Morito
Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Oncology reports 2007;18(4):801-9.
2007: Damdinsuren Bazarragchaa; Nagano Hiroaki; Monden Morito
Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 2():S238-50.
2007: Shimoda Masafumi; Marubashi Shigeru; Dono Keizo; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Monden Morito
Utilization of autologous vein graft for replacement of the inferior vena cava in living-donor liver transplantation for obliterative hepatocavopathy.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(9):804-7.
2007: Tsujie Masanori; Nakamori Shoji; Nakahira Shin; Takahashi Yuji; Hayashi Nobuyasu; Okami Jiro; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
Anticancer research 2007;27(4B):2241-9.
2007: Marubashi Shigeru; Dono Keizo; Nagano Hiroaki; Sugita Yukari; Asaoka Tadafumi; Hama Naoki; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Monden Morito
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(7):576-82.
2007: Wada Hiroshi; Nagano Hiroaki; Noda Takehiro; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Sakon Masato; Wakasa Kenichi; Monden Morito
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Journal of gastroenterology 2007;42(6):501-6.
2007: Nagano Hiroaki; Sakon Masato; Monden Morito
[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration]
Nippon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology 2007;104(5):654-9.
2007: Yamamoto Tameyoshi; Nagano Hiroaki; Imai Yasuharu; Fukuda Kazuto; Matsumoto Hitoshi; Kondo Motoi; Ota Hideo; Nakamura Masato; Wada Hiroshi; Noda Takehiro; Damdinsuren Bazarragchaa; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sakon Masato; Wakasa Kenichi; Monden Morito
Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
International journal of clinical oncology / Japan Society of Clinical Oncology 2007;12(2):150-4.
2007: Hashimoto Kazuhiko; Murakami Takamichi; Dono Keizo; Hori Masatoshi; Kim Tonsok; Kudo Masayuki; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Nakamura Hironobu; Monden Morito
Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT.
Digestive diseases and sciences 2007;52(4):943-9.
2007: Nakahira Shin; Nakamori Shoji; Tsujie Masanori; Takahashi Yuji; Okami Jiro; Yoshioka Shinichi; Yamasaki Makoto; Marubashi Shigeru; Takemasa Ichiro; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.
International journal of cancer. Journal international du cancer 2007;120(6):1355-63.
2007: Yang Yubo; Nagano Hiroaki; Ota Hideo; Morimoto Osakuni; Nakamura Masato; Wada Hiroshi; Noda Takehiro; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Kenichi; Sakon Masato; Monden Morito
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
Surgery 2007;141(2):196-202.
2007: Nagano Hiroaki; Sakon Masato; Eguchi Hidetoshi; Kondo Motoi; Yamamoto Tameyoshi; Ota Hideo; Nakamura Masato; Wada Hiroshi; Damdinsuren Bazarragcha; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshit Koji; Nakamori Shoji; Monden Morito
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
Hepato-gastroenterology 2007;54(73):172-9.
2007: Arai Isao; Nagano Hiroaki; Kondo Motoi; Yamamoto Hirofumi; Hiraoka Nobuaki; Sugita Yurika; Ota Hideo; Yoshioka Shinichi; Nakamura Masato; Wada Hiroshi; Damdinsuren Bazarragchaa; Kato Hitoshi; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Kenichi; Sakon Masato; Monden Morito
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Hepato-gastroenterology 2007;54(73):167-71.
2007: Damdinsuren Bazarragchaa; Nagano Hiroaki; Wada Hiroshi; Noda Takehiro; Natsag Javzandulam; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Doki Yuichiro; Dono Keizo; Monden Morito
Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(1):77-83.
2007: Damdinsuren Bazarragchaa; Nagano Hiroaki; Wada Hiroshi; Kondo Motoi; Ota Hideo; Nakamura Masato; Noda Takehiro; Natsag Javzandulam; Yamamoto Hirofumi; Doki Yuichiro; Umeshita Koji; Dono Keizo; Nakamori Shoji; Sakon Masato; Monden Morito
Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
International journal of oncology 2007;30(1):201-8.
2007: Nakamura Masato; Nagano Hiroaki; Sakon Masato; Yamamoto Tameyoshi; Ota Hideo; Wada Hiroshi; Damdinsuren Bazarragchaa; Noda Takehiro; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Nakamori Shoji; Dono Keizo; Monden Morito
Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Journal of hepatology 2007;46(1):77-88.
2006: Marubashi S; Dono K; Sugita Y; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Transplantation proceedings 2006;38(10):3640-2.
2006: Wada Hiroshi; Nagano Hiroaki; Noda Takehiro; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Wakasa Kenichi; Monden Morito
[Surgical treatment for peritoneal dissemination of hepatocellular carcinoma after percutaneous ethanol injection therapy--a case report]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1935-7.
2006: Noda Takehiro; Nagano Hiroaki; Miyamoto Atsushi; Wada Hiroshi; Damdinsuren Bazarragchaa; Marubashi Shigeru; Takeda Yutaka; Umeshita Koji; Dono Keizo; Ohsuga Keigo; Kim Tonsok; Tomoda Kaname; Nakamura Hironobu; Monden Morito
[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1931-4.
2006: Nagano Hiroaki; Miyamoto Atsushi; Wada Hiroshi; Noda Takehiro; Nakamura Masato; Ota Hideo; Damdinsuren Bazarragchaa; Marubashi Shigeru; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
[Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1848-51.
2006: Nakamura Masato; Nagano Hiroaki; Wada Hiroshi; Noda Takehiro; Ota Hideo; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
Journal of gastroenterology 2006;41(11):1120-5.
2006: Hashimoto Kazuhiko; Murakami Takamichi; Dono Keizo; Hori Masatoshi; Kim Tonsok; Kudo Masayuki; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Nakamura Hironobu; Monden Morito
Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging.
Oncology reports 2006;16(4):677-83.
2006: Noda Takehiro; Nagano Hiroaki; Wada Hiroshi; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Ohsuga Keigo; Kim Tonsok; Tomoda Kaname; Nakamura Hironobu; Monden Morito
[The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(9):1221-5.
2006: Tsujie Masanori; Nakamori Shoji; Nakahira Shin; Takeda Setsuo; Takahashi Yuji; Hayashi Nobuyasu; Okami Jiro; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Pancreas 2006;33(2):142-7.
2006: Tsujie Masanori; Nakamori Shoji; Tanaka Eiichi; Nagano Hiroaki; Umeshita Koji; Dono Keizo; Sakon Masato; Inoue Takehiro; Inoue Toshihiko; Monden Morito
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Japanese journal of clinical oncology 2006;36(8):504-10.
2006: Ota Hideo; Nagano Hiroaki; Doki Yuichiro; Sekimoto Mitsugu; Kondo Motoi; Wada Hiroshi; Nakamura Masato; Noda Takehiro; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Kenichi; Sakon Masato; Monden Morito
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
Oncology reports 2006;16(2):249-55.
2006: Nakamura Masato; Nagano Hiroaki; Noda Takehiro; Wada Hiroshi; Ota Hideo; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Doki Yuichiro; Umeshita Koji; Dono Keizo; Sakon Masato; Monden Morito
Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;35(4):289-95.
2006: Tang Di; Nagano Hiroaki; Nakamura Masato; Wada Hiroshi; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2006;10(7):987-98.
2006: Nagano Hiroaki; Monden Morito
[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma]
Nippon rinsho. Japanese journal of clinical medicine 2006;64(7):1314-8.
2006: Takahashi Hidenori; Nakamori Shoji; Nakahira Shin; Tsujie Masanori; Takahshi Yuji; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
Annals of surgical oncology 2006;13(7):955-60.
2006: Nakamura Masato; Nagano Hiroaki; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
[S-1 treatment against advanced HCC]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():230-5.
2006: Marubashi S; Dono K; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation.
Transplantation proceedings 2006;38(5):1407-10.
2006: Wada Hiroshi; Nagano Hiroaki; Yamamoto Hirofumi; Yang Yubo; Kondo Motoi; Ota Hideo; Nakamura Masato; Yoshioka Shinichi; Kato Hitoshi; Damdinsuren Bazarragchaa; Tang Di; Marubashi Sigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Nakamori Shoji; Sakon Masato; Dono Keizo; Wakasa Kenichi; Monden Morito
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):414-23.
2006: Tang Di; Nagano Hiroaki; Yamamoto Hirofumi; Wada Hiroshi; Nakamura Masato; Kondo Motoi; Ota Hideo; Yoshioka Shinichi; Kato Hitoshi; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Wakasa Kenichi; Monden Morito
Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
Oncology reports 2006;15(3):525-32.
2006: Yoshida Kenya; Tomita Yasuhiko; Okuda Yorihide; Yamamoto Shinji; Enomoto Hirayuki; Uyama Hirokazu; Ito Hiroaki; Hoshida Yoshihiko; Aozasa Katsuyuki; Nagano Hiroaki; Sakon Masato; Kawase Ichiro; Monden Morito; Nakamura Hideji
Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Annals of surgical oncology 2006;13(2):159-67.
2006: Damdinsuren Bazarragchaa; Nagano Hiroaki; Kondo Motoi; Natsag Javzandulam; Hanada Hiroyuki; Nakamura Masato; Wada Hiroshi; Kato Hitoshi; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
Oncology reports 2006;15(2):401-8.
2006: Marubashi Shigeru; Dono Keizo; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Monden Morito
Liver transplantation for hepatitis C.
Journal of hepato-biliary-pancreatic surgery 2006;13(5):382-92.
2005: Marubashi Shigeru; Dono Keizo; Nagano Hiroaki; Gotoh Kunihito; Takahashi Hidenori; Hashimoto Kazuhiko; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Kato Tomoaki; Monden Morito
Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts.
Transplantation 2005;80(12):1671-5.
2005: Hayashi Shouho; Dono Keizo; Shimizu Junzo; Murakami Takamichi; Takamura Manabu; Kim Tonsok; Hori Masatoshi; Lu Zhenhui; Nagano Hiroaki; Nakamori Shoji; Sakon Masato; Nakamura Hironobu; Monden Morito
New measurement of hepatic blood flow by xenon CT system: an animal study with PGE1.
The Journal of surgical research 2005;129(1):24-30.
2005: Kato Hitoshi; Nagano Hiroaki; Ota Hideo; Nakamura Masato; Wada Hiroshi; Yoshioka Shinichi; Noda Takahiro; Bazarragchaa Damdinsuren; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Murakami Takamichi; Nakamura Hironobu; Monden Morito
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1842-5.
2005: Wada Hiroshi; Nagano Hiroaki; Nakamura Masato; Yoshioka Shinichi; Kato Hitoshi; Noda Takehiro; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Dono Keizo; Monden Morito
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1835-8.
2005: Nakamura Masato; Nagano Hiroaki; Sakon Masato; Yamamoto Tameyoshi; Ota Hideo; Wada Hiroshi; Yoshioka Shinichi; Kato Hitoshi; Damdinsuren Bazarragchaa; Marubashi Shigeru; Miyamoto Atsushi; Takeda Yutaka; Umeshita Koji; Nakamori Shoji; Dono Keizo; Monden Morito
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1824-8.
2005: Marubashi Shigeru; Dono Keizo; Amano Koji; Hama Naoki; Gotoh Kunihito; Takahashi Hidenori; Hashimoto Kazuhiko; Miyamoto Atsushi; Takeda Yutaka; Nagano Hiroaki; Umeshita Koji; Monden Morito
Steroid-free living-donor liver transplantation in adults.
Transplantation 2005;80(5):704-6.
2005: Ota H; Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Nakamura M; Damdinsuren B; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
British journal of cancer 2005;93(5):557-64.
2005: Marubashi Shigeru; Dono Keizo; Sakon Masato; Gotoh Kunihito; Takahashi Hidenori; Hashimoto Kazuhiko; Kubota Masaru; Yamamoto Shinji; Miyamoto Atsushi; Nagano Hiroaki; Nakamori Shoji; Umeshita Koji; Monden Morito
Portal venous reconstruction in a living liver donor with an anomalous hepatic arterial and portal venous anatomy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2005;9(3):365-8.
2005: Kondo Motoi; Nagano Hiroaki; Wada Hiroshi; Damdinsuren Bazarragchaa; Yamamoto Hirofumi; Hiraoka Nobuaki; Eguchi Hidetoshi; Miyamoto Atsushi; Yamamoto Tameyoshi; Ota Hideo; Nakamura Masato; Marubashi Shigeru; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1277-86.
2005: Damdinsuren Bazarragchaa; Nagano Hiroaki; Kondo Motoi; Yamamoto Hirofumi; Hiraoka Nobuaki; Yamamoto Tameyoshi; Marubashi Shigeru; Miyamoto Atsushi; Umeshita Koji; Dono Keizo; Nakamori Shoji; Wakasa Ken-Ichi; Sakon Masato; Monden Morito
Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
International journal of oncology 2005;26(2):319-27.
2005: Morimoto Osakuni; Nagano Hiroaki; Miyamoto Atsushi; Fujiwara Yoshiyuki; Kondo Motoi; Yamamoto Tameyoshi; Ota Hideo; Nakamura Masato; Wada Hiroshi; Damdinsuren Bazarragchaa; Marubashi Shigeru; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Surgery today 2005;35(12):1033-41.
2004: Osuga Keigo; Murakami Takamichi; Nakata Saki; Tomoda Kaname; Nagano Hiroaki; Monden Morito; Nakamura Hironobu
[Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(13):2114-7.
2004: Yamamoto Tameyoshi; Nagano Hiroaki; Sakon Masato; Wada Hisashi; Eguchi Hidetoshi; Kondo Motoi; Damdinsuren Bazarragchaa; Ota Hideo; Nakamura Masato; Wada Hiroshi; Marubashi Shigeru; Miyamoto Atsushi; Dono Keizo; Umeshita Koji; Nakamori Shoji; Yagita Hideo; Monden Morito
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7884-95.
2004: Marubashi Shigeru; Sakon Masato; Nagano Hiroaki; Gotoh Kunihito; Hashimoto Kazuhiko; Kubota Masaru; Kobayashi Shogo; Yamamoto Shinji; Miyamoto Atsushi; Dono Keizo; Nakamori Shoji; Umeshita Koji; Monden Morito
Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model.
Surgery 2004;136(5):1028-37.
2004: Nakamura Masato; Nagano Hiroaki; Sakon Masato; Kondo Motoi; Yamamoto Tameyoshi; Ota Hideo; Wada Hiroshi; Damdinsuren Bazarragchaa; Yang Yubo; Marubashi Shigeru; Miyamoto Atsushi; Dono Keizo; Umeshita Koji; Nakamori Shoji; Monden Morito
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1939-42.
2004: Kimura Yutaka; Yasuda Takushi; Fujiwara Yoshiyuki; Takiguchi Shuji; Miyata Hiroshi; Nagano Hiroaki; Yano Masahiko; Monden Morito
[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1825-7.
2004: Wada Hiroshi; Nagano Hiroaki; Dono Keizo; Kondo Motoi; Yamamoto Tameyoshi; Ota Hideo; Nakamura Masato; Yoshioka Shinichi; Damdinsuren Bazarragchaa; Yubo Yang; Marubashi Shigeru; Miyamoto Atsushi; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1711-3.
2004: Marubashi Shigeru; Dono Keizo; Takahashi Hidenori; Hashimoto Kazuhiko; Kubota Masaru; Yamamoto Shinji; Miyamoto Atsushi; Nagano Hiroaki; Nakamori Shoji; Umeshita Koji; Sakon Masato; Monden Morito
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1708-10.
2004: Jin Chang De; Yamamoto Tameyoshi; Nakamura Masato; Arai Isao; Kishin Rho; Xing Xu; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(10):1511-5.
2004: Kurokawa Yukinori; Matoba Ryo; Nagano Hiroaki; Sakon Masato; Takemasa Ichiro; Nakamori Shoji; Dono Keizo; Umeshita Koji; Ueno Noriko; Ishii Shin; Kato Kikuya; Monden Morito
Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6029-38.
2004: Yamamoto Shinji; Tomita Yasuhiko; Hoshida Yoshihiko; Iizuka Norishige; Marubashi Shigeru; Miyamoto Atsushi; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sakon Masato; Aozasa Katsuyuki; Monden Morito
Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
Journal of gastroenterology 2004;39(8):793-7.
2004: Kurokawa Yukinori; Matoba Ryo; Takemasa Ichiro; Nagano Hiroaki; Dono Keizo; Nakamori Shoji; Umeshita Koji; Sakon Masato; Ueno Noriko; Oba Shigeyuki; Ishii Shin; Kato Kikuya; Monden Morito
Molecular-based prediction of early recurrence in hepatocellular carcinoma.
Journal of hepatology 2004;41(2):284-91.
2004: Yamamoto Shinji; Tomita Yasuhiko; Hoshida Yoshihiko; Morooka Takaya; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Ishikawa Osamu; Ohigashi Hiroaki; Nakamori Shoji; Monden Morito; Aozasa Katsuyuki
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2846-50.
2004: Murakami Takamichi; Hori Masatoshi; Kim Tonsok; Hashimoto Kazuhiko; Dono Keizo; Hayashi Shoho; Sugihara Eiji; Nagano Hiroaki; Sase Shigeru; Sakon Masato; Monden Morito; Nakamura Hironobu
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma.
Investigative radiology 2004;39(4):210-5.
2004: Kurokawa Y; Matoba R; Nakamori S; Takemasa I; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Kato K
PCR-array gene expression profiling of hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR 2004;23(1):135-41.
2004: Kobayashi Shogo; Hori Masatoshi; Dono Keizo; Nagano Hiroaki; Umeshita Koji; Nakamori Shoji; Sakon Masato; Osuga Keigo; Umetani Keiji; Murakami Takamichi; Nakamura Hironobu; Monden Morito
In vivo real-time microangiography of the liver in mice using synchrotron radiation.
Journal of hepatology 2004;40(3):405-8.
2004: Ogawa Minoru; Yamamoto Hirofumi; Nagano Hiroaki; Miyake Yasuhiro; Sugita Yurika; Hata Taishi; Kim Byung-No; Ngan Chew Yee; Damdinsuren Bazarragchaa; Ikenaga Masakazu; Ikeda Masataka; Ohue Masayuki; Nakamori Shoji; Sekimoto Mitsugu; Sakon Masato; Matsuura Nariaki; Monden Morito
Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
Hepatology (Baltimore, Md.) 2004;39(2):528-39.
2004: Yamamoto Shinji; Tomita Yasuhiko; Hoshida Yoshihiko; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Ishikawa Osamu; Ohigashi Hiroaki; Nakamori Shoji; Monden Morito; Aozasa Katsuyuki
Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Annals of surgical oncology 2004;11(2):165-72.
2004: Aoki Taro; Miyamoto Atsushi; Marubashi Shigeru; Nagano Hiroaki; Umeshita Koji; Fujiwara Yoshiyuki; Dono Keizo; Nakamori Shoji; Sakon Masato; Monden Morito
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
International journal of oncology 2004;24(2):441-6.
2004: Nakamori Shoji; Tujie Masanori; Takahashi Yuji; Maruhashi Shigeru; Miyamoto Atsushi; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(1):51-4.
2004: Xu Xundi; Sakon Masato; Nagano Hiroaki; Hiraoka Nobuaki; Yamamoto Hirofumi; Hayashi Nobuyasu; Dono Keizo; Nakamori Shoji; Umeshita Koji; Ito Yasuhiro; Matsuura Nariaki; Monden Morito
Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
Oncology reports 2004;11(1):25-32.
2004: Yamamoto Shinji; Tomita Yasuhiko; Nakamori Shoji; Hoshida Yoshihiko; Iizuka Norishige; Okami Jiro; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Ishikawa Osamu; Ohigashi Hiroaki; Aozasa Katsuyuki; Monden Morito
Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
Oncology 2004;66(6):468-75.
2004: Hayashi Nobuyasu; Nakamori Shoji; Okami Jiro; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Narimatsu Hisashi; Monden Morito
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):26-34.
2004: Yamamoto Shinji; Nakamori Shoji; Tsujie Masanori; Takahashi Yuji; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Tomita Yasuhiko; Hoshida Yoshihiko; Aozasa Katsuyuki; Kohno Kimitoshi; Monden Morito
Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):12-8.
2003: Damdinsuren Bazarragchaa; Nagano Hiroaki; Sakon Masato; Kondo Motoi; Yamamoto Tameyoshi; Umeshita Koji; Dono Keizo; Nakamori Shoji; Monden Morito
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Annals of surgical oncology 2003;10(10):1184-90.
2003: Kurokawa Yukinori; Matoba Ryo; Takemasa Ichiro; Nakamori Shoji; Tsujie Masanori; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Ueno Noriko; Kita Hiroko; Oba Shigeyuki; Ishii Shin; Kato Kikuya; Monden Morito
Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study.
Journal of hepatology 2003;39(6):1004-12.
2003: Nagano Hiroaki; Sakon Masato; Monden Morito
[The chemotherapy for hepatocellular carcinoma]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(12):1895-900.
2003: Okami Jiro; Dono Keizo; Sakon Masato; Tsujie Masanori; Hayashi Nobuyasu; Fujiwara Yoshiyuki; Nagano Hiroaki; Umeshita Koji; Nakamori Shoji; Monden Morito
Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(7):850-6.
2003: Nakamura Masato; Nagano Hiroaki; Sakon Masato; Yamamoto Tameyoshi; Ota Hideo; Marubashi Shigeru; Miyamoto Atsushi; Dono Keizo; Umeshita Koji; Nakamori Shoji; Hiramatsu Naoki; Hayashi Norio; Monden Morito
[A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1717-21.
2003: Ota Hideo; Nagano Hiroaki; Sakon Masato; Yamamoto Tameyoshi; Nakamura Masato; Marubashi Shigeru; Miyamoto Atsushi; Dono Keizo; Umeshita Koji; Nakamori Shoji; Murakami Takamichi; Nakamura Hironobu; Monden Morito
[A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1673-7.
2003: Tsujie Masanori; Nakamori Shoji; Okami Jiro; Hayashi Nobuyasu; Hiraoka Nobuaki; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Experimental cell research 2003;289(1):143-51.
2003: Shimizu Junzo; Oka Hiroshi; Dono Keizo; Sakon Masato; Takamura Manabu; Murakami Takamichi; Hayashi Shouho; Nagano Hiroaki; Nakamori Shoji; Umeshita Koji; Sase Shigeru; Gotoh Mitsukazu; Wakasa Kenichi; Nakamura Hironobu; Monden Morito
Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.
Digestive diseases and sciences 2003;48(8):1510-6.
2003: Yamamoto Hirofumi; Kondo Motoi; Nakamori Shoji; Nagano Hiroaki; Wakasa Ken-Ichi; Sugita Yurika; Chang-De Jin; Kobayashi Shogo; Damdinsuren Bazarragchaa; Dono Keizo; Umeshita Koji; Sekimoto Mitsugu; Sakon Masato; Matsuura Nariaki; Monden Morito
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Gastroenterology 2003;125(2):556-71.
2003: Morimoto Osakuni; Nagano Hiroaki; Sakon Masato; Fujiwara Yoshiyuki; Yamada Terumasa; Nakagawa Hidewaki; Miyamoto Atsushi; Kondo Motoi; Arai Isao; Yamamoto Tameyoshi; Ota Hideo; Dono Keizo; Umeshita Koji; Nakamori Shoji; Sasaki Yo; Ishikawa Osamu; Imaoka Shingi; Monden Morito
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.
Journal of hepatology 2003;39(2):215-21.
2003: Tsujie Masanori; Nakamori Shoji; Okami Jiro; Takahashi Yuji; Hayashi Nobuyasu; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
International journal of oncology 2003;23(2):325-31.
2003: Kobayashi Shogo; Dono Keizo; Takahara Shiro; Isaka Yoshitaka; Imai Enyu; Zhenhui Lu; Nagano Hiroaki; Tomoaki Kato; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation.
The journal of gene medicine 2003;5(6):510-7.
2003: Miyamoto Atsushi; Kato Tomoaki; Dono Keizo; Umeshita Koji; Kawabata Ryohei; Hayashi Shoho; Kubota Masaru; Kobayashi Shogo; Nagano Hiroaki; Nakamori Shoji; Sakon Masato; Monden Morito
Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral.
Transplantation 2003;75(9):1596-8.
2003: Xu Xundi; Yamamoto Hirofumi; Sakon Masato; Yasui Masayoshi; Ngan Chew Yee; Fukunaga Hiroki; Morita Tetsushi; Ogawa Minoru; Nagano Hiroaki; Nakamori Shoji; Sekimoto Mitsugu; Matsuura Nariaki; Monden Morito
Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1764-72.
2003: Kondo Motoi; Nagano Hiroaki; Sakon Masato; Hayashi Shouho; Okami Jiro; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Ken-ichi; Monden Morito
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma.
Hepato-gastroenterology 2003;50(50):504-6.
2003: Kobayashi Shogo; Dono Keizo; Tanaka Toshiyuki; Takahara Shiro; Isaka Yoshitaka; Imai Enyu; Nagano Hiroaki; Tomoaki Kato; Umeshita Koji; Nakamori Shoji; Sakon Masato; Monden Morito
Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation.
The journal of gene medicine 2003;5(3):201-8.
2003: Tsujie Masanori; Nakamori Shoji; Nakazuru Shoichi; Hayashi Nobuyasu; Okami Jiro; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(2):297-301.
2003: Yamamoto Shinji; Tomita Yasuhiko; Nakamori Shoji; Hoshida Yoshihiko; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito; Aozasa Katsuyuki
Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):447-52.
2003: Okami Jiro; Nakamori Shoji; Hiraoka Nobuaki; Tsujie Masanori; Hayashi Nobuyasu; Yamamoto Hirofumi; Fujiwara Yoshiyuki; Nagano Hiroaki; Dono Keizo; Umeshita Koji; Sakon Masato; Monden Morito
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.
Clinical & experimental metastasis 2003;20(7):577-84.
2002: Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Journal of experimental & clinical cancer research : CR 2002;21(4):569-76.
2002: Yamamoto Tameyoshi; Nagano Hiroaki; Sakon Masato; Yasuda Takushi; Takemoto Hiroyoshi; Tsujino Tadashi; Ota Hideo; Dono Keizo; Umeshita Koji; Nakamori Shoji; Yano Masahiko; Osuga Keigo; Murakami Takamichi; Nakamura Hironobu; Monden Morito
[A case of postoperative multiple hepatic metastasis from gastric cancer successfully treated by percutaneous microwave coagulation therapy and hepatic arterial infusion chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2429-32.
2002: Ota Hideo; Nagano Hiroaki; Sakon Masato; Inoue Tsuyoshi; Hayashi Shoho; Kondo Motoi; Arai Isao; Morimoto Osakuni; Yamamoto Tameyoshi; Nakamura Masato; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Kenichi; Monden Morito
[Hepatocellular carcinoma recurrence in PEI site--a case report]
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2421-4.
2002: Nagano Hiroaki; Sakon Masato; Monden Morito
[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy]
Nippon rinsho. Japanese journal of clinical medicine 2002;60(11):2237-44.
2002: Osuga Keigo; Khankan Azzam Anwar; Hori Shinichi; Okada Atsuya; Sugiura Takashi; Maeda Munehiro; Nagano Hiroaki; Yamada Akira; Murakami Takamichi; Nakamura Hironobu
Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience.
Journal of vascular and interventional radiology : JVIR 2002;13(9 Pt 1):929-34.
2002: Kondo Motoi; Dono Keizo; Sakon Masato; Shimizu Junzo; Nagano Hiroaki; Nakamori Shoji; Umeshita Koji; Wakasa Ken-ichi; Monden Morito
Adenosquamous carcinoma of the gallbladder.
Hepato-gastroenterology 2002;49(47):1230-4.
2002: Sakon Masato; Nagano Hiroaki; Dono Keizo; Nakamori Shoji; Umeshita Koji; Yamada Akira; Kawata Sumio; Imai Yasuharu; Iijima Shohei; Monden Morito
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.
Cancer 2002;94(2):435-42.
2002: Sakon Masato; Nagano Hiroaki; Nakamori Shoji; Dono Keizo; Umeshita Koji; Murakami Takamichi; Nakamura Hironobu; Monden Morito
Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(1):94-9.
2002: Eguchi Hidetoshi; Nagano Hiroaki; Sakon Masato; Miyamoto Atsushi; Kondo Motoi; Arai Isao; Morimoto Osakuni; Dono Keizo; Umeshita Koji; Nakamori Shoji; Wakasa Kenichi; Monden Morito
A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.
Surgery today 2002;32(8):742-6.
2002: Morimoto Osakuni; Nagano Hiroaki; Sakon Masato; Eguchi Hidetoshi; Miyamoto Atsushi; Kondo Motoi; Arai Isao; Yamamoto Tameyoshi; Dono Keizo; Umeshita Koji; Takamura Manabu; Murakami Takamichi; Nakamori Shoji; Nakamura Hironobu; Monden Morito
Liver abscess formation after microwave coagulation therapy applied for hepatic metastases from surgically excised bile duct cancer: report of a case.
Surgery today 2002;32(5):454-7.
2001: Nagano H; Eguchi H; Sakon M; Monden M
[Hepatic arterial infusion chemotherapy combined with interferon-alpha for hepatocellular carcinoma]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():748-52.
2001: Yamamoto T; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M
[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1718-23.
2001: Nagano H; Sakon M; Yasuda T; Dono K; Nakamori S; Yano M; Umeshita K; Shiozaki H; Okada A; Murakami T; Nakamura H; Monden M
[A case of postoperative multiple hepatic metastasis from esophageal cancer successfully treated by surgical resection and hepatic arterial infusion chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1628-31.
2001: Noura S; Sekimoto M; Yamamoto H; Ikeda M; Ikenaga M; Miyake Y; Yokoyama S; Nagano H; Sakon M; Monden M
[Significance of liver resection for multiple hepatic metastases from colorectal cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1550-3.
2001: Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hepatology (Baltimore, Md.) 2001;34(4 Pt 1):638-50.
2001: Shiozaki K; Nakamori S; Tsujie M; Okami J; Yamamoto H; Nagano H; Dono K; Umeshita K; Sakon M; Furukawa H; Hiratsuka M; Kasugai T; Ishiguro S; Monden M
Human stomach-specific gene, CA11, is down-regulated in gastric cancer.
International journal of oncology 2001;19(4):701-7.
2001: Miyamoto A; Nagano H; Sakon M; Fujiwara Y; Sugita Y; Eguchi H; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Monden M
Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR.
International journal of oncology 2001;18(3):527-32.
2001: Wang M; Sakon M; Umeshita K; Okuyama M; Shiozaki K; Nagano H; Dohno K; Nakamori S; Monden M
Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain mu activation.
Journal of hepatology 2001;34(2):278-83.
2001: Sakon M; Aono Y; Ariyoshi H; Ueda A; Tsuji Y; Umeshita K; Nagano H; Dono K; Nakamori S; Monden M
Involvement of calcium influx in hypoxia-induced bleb formation in human umbilical vein endothelial cells.
Transplantation proceedings 2001;33(1-2):898.
2000: Miyamoto A; Umeshita K; Sakon M; Nagano H; Eguchi H; Kishimoto S; Dono K; Nakamori S; Gotoh M; Monden M
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Journal of gastroenterology and hepatology 2000;15(12):1447-51.
2000: Sakon M; Umeshita K; Nagano H; Eguchi H; Kishimoto S; Miyamoto A; Ohshima S; Dono K; Nakamori S; Gotoh M; Monden M
Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves.
Archives of surgery (Chicago, Ill. : 1960) 2000;135(12):1456-9.
2000: He L; Dono K; Gotoh M; Okumura M; Takeda Y; Shimizu J; Nagano H; Nakamori S; Umeshita K; Sakon M; Monden M
Role of the liver in alloimmune response following inoculation of donor spleen cells.
Cell transplantation 2000;9(5):725-8.
2000: Eguchi H; Umeshita K; Sakon M; Nagano H; Ito Y; Kishimoto S I; Dono K; Nakamori S; Takeda T; Gotoh M; Wakasa K; Matsuura N; Monden M
Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.
Digestive diseases and sciences 2000;45(7):1383-8.
2000: Miyamoto A; Fujiwara Y; Sakon M; Nagano H; Sugita Y; Kondo M; Eguchi H; Dono K; Umeshita K; Nakamori S; Monden M
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Digestive diseases and sciences 2000;45(7):1376-82.
2000: Eguchi H; Nagano H; Yamamoto H; Miyamoto A; Kondo M; Dono K; Nakamori S; Umeshita K; Sakon M; Monden M
Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2881-90.
2000: Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
International journal of oncology 2000;17(1):83-8.
2000: Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2326-32.
2000: Kishimoto S; Sakon M; Umeshita K; Miyoshi H; Taniguchi K; Meng W; Nagano H; Dono K; Ariyosi H; Nakamori S; Kawasaki T; Gotoh M; Monden M; Imajoh-Ohmi S
The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation.
Transplantation 2000;69(11):2314-9.
2000: Yamada T; Nakamori S; Ohzato H; Higaki N; Aoki T; Oshima S; Shiozaki K; Okami J; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Outcome of pancreatic cancer patients based on genetic lymph node staging.
International journal of oncology 2000;16(6):1165-71.
2000: Fujiwara Y; Sugita Y; Nakamori S; Miyamoto A; Shiozaki K; Nagano H; Sakon M; Monden M
Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.
International journal of oncology 2000;16(4):799-804.
2000: Ito Y; Monden M; Takeda T; Eguchi H; Umeshita K; Nagano H; Nakamori S; Dono K; Sakon M; Nakamura M; Tsujimoto M; Nakahara M; Nakao K; Yokosaki Y; Matsuura N
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
British journal of cancer 2000;82(6):1211-7.
1999: Gotoh K; Nagano H; Sakon M; Miyamoto A; Shimizu J; Taniguchi H; Dono K; Nakamori S; Umeshita K; Gotoh M; Nakamura H; Wakasa K; Monden M
[A case of mucinous cholangiocarcinoma with lymph node metastasis]
Nippon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology 1999;96(12):1401-6.
1999: Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4005-12.
1999: Ito Y; Matsuura N; Sakon M; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Monden M
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
British journal of cancer 1999;81(4):747-51.
1999: Shimizu J; Nagano H; Sakon M; Dono K; Takeda Y; Kishimoto S; Eguchi H; Miyamoto A; Kondo M; Nakamori S; Umeshita K; Nakamura H; Wakasa K; Monden M
[A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(12):1895-9.
1999: He L; Gotoh M; Dono K; Nagano H; Ota H; Ohta Y; Okuyama M; Takeda Y; Shimizu J; Grochowiecki T; Sakon M; Monden M
Participation of the liver in generation of a vigorous anti-donor response after inoculation of donor spleen cells.
Transplantation 1999;68(7):950-7.
1999: Nakamori S; Nishihara S; Ikehara Y; Nagano H; Dono K; Sakon M; Narimatsu H; Monden M
Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas.
Journal of experimental & clinical cancer research : CR 1999;18(3):425-32.
1999: Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2018-24.
1999: Shimizu J; Dono K; Gotoh M; Hasuike Y; Kim T; Murakami T; Sakon M; Umeshita K; Nagano H; Nakamori S; Kato N; Miyazawa T; Nakamura H; Monden M
Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging.
Digestive diseases and sciences 1999;44(7):1330-7.
1999: Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Hepatology (Baltimore, Md.) 1999;30(1):90-9.
1999: Grtochowiecki T; Gotoh M; Dono K; Takeda Y; Nishihara M; Ohta Y; Ota H; Ohzato H; Okuyama M; Shimizu J; Kimura F; He L; Nagano H; Nakamori S; Umeshita K; Sakon M; Monden M
Pretreatment of crude pancreatic islets with mitomycin C prolongs graft survival time in xenogeneic rat-to-mouse model.
Transplantation 1999;67(11):1474-7.
1999: Tanigawa T; Gotoh M; Nagano H; Ota H; Fukuzaki T; Sakon M; Monden M
Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats.
Transplantation 1999;67(5):653-8.
1999: Grochowiecki T; Gotoh M; Dono K; Takeda Y; Ohzato H; Okuyama M; Shimizu J; Kimura F; He L; Nagano H; Nakamori S; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka; Monden M
Pretreatment of islets with mitomycin C and blockage of costimulatory signal induces unresponsiveness to islet xenografts.
Transplantation proceedings 1999;31(1-2):925.
1999: Takeda Y; Gotoh M; Dono K; Grochowiecki T R; Kimura F; Okuyama M; Shimizu J; Nagano H; Umeshita K; Sakon M; Miyasaka M; Monden M
Acceptance of islet allografts transplanted with Fas ligand expressing testicular allografts.
Transplantation proceedings 1999;31(1-2):624.
1999: Umeshita K; Gotoh M; Shimizu J; Takeda Y; Nagano H; Dono K; Nakamori S; Sakon M; Okamura J; Monden M
Evaluation of patient selection criteria for liver transplantation: eight-year experience.
Transplantation proceedings 1999;31(1-2):376-7.
1999: Ota H; Gotoh M; Ohzato H; He L; Tanigawa T; Nagano H; Dono K; Takeda Y; Okuyama M; Shimizu J; Umeshita K; Nakamori S; Sakon M; Nishisho I; Monden M
Microchimerism in thymus is associated with up-regulated T helper type 1 cytokine transcription during cardiac allograft rejection in rats.
Transplantation 1999;67(1):165-73.
1996: Tanigawa T; Gotoh M; Ota H; Nagano H; Ohzato H; Hasuike Y; Sakon M; Monden M
Prolongation of cardiac allograft survival by intraportal injection of donor antigens--differential mechanisms according to the timing of injection.
Cell transplantation 1996;5(5 Suppl 1):S79-80.
1995: Nagano H; Tanigawa T; Yoshida T; Ota H; Akagi K; Hasuike Y; Gotoh M; Nishisho I; Monden M
Role of micro-chimerism in inducing immunological tolerance by intraportal injection of donor spleen cells in rats.
Cell transplantation 1995;4 Suppl 1():S59-60.
1994: Nagano H; Monden M; Gotoh M; Tanigawa T; Hasuike Y; Akagi K; Yoshida T; Ota H; Nishisho I; Mori T
Existence of microchimerism in the spleen after intraportal injection in molecular-biological and immunofluorescence study.
Transplantation proceedings 1994;26(6):3471.
1994: Tanigawa T; Monden M; Gotoh M; Nagano H; Hasuike Y; Fukuzaki T; Akagi K; Yoshida T; Ota H; Mori T
Pretreatment of recipients with mitomycin-C-treated spleen cells induces significant prolongation of cardiac allograft survival in rats.
Transplantation proceedings 1994;26(6):3359-60.
1994: Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
Portal tolerance in rats: effect of donor cell treatment and timing of administration.
Transplantation proceedings 1994;26(4):1870-1.
1994: Nagano H; Monden M; Gotoh M; Tanigawa T; Hasuike Y; Akagi K; Yoshida T; Ota H; Nishisho I; Mori T
Restriction fragment length polymorphism analysis to detect microchimerism at the DNA level in rats.
Transplantation proceedings 1994;26(4):1970-1.
1994: Fukuzaki T; Gotoh M; Hasuike Y; Tanigawa T; Nagano H; Umeshita K; Kanai T; Monden M; Mori T
Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.
Transplantation proceedings 1994;26(2):779.
1993: Nagano H; Monden M; Gotoh M; Tanigawa T; Tono T; Nakano Y; Mori T
Induction of unresponsiveness in rats after either intraportal injection of donor antigen or intravenous injection combined with splenectomy.
Transplantation 1993;56(6):1468-72.
1993: Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
Transplantation proceedings 1993;25(1 Pt 1):352-3.
1992: Nagano H; Monden M; Gotoh M; Nakano Y; Tono T; Fukuzaki T; Tanigawa T; Mori T
Mechanisms involved in immunosuppression induced by intraportal injection of donor spleen cells in rats.
Transplantation proceedings 1992;24(6):2900-1.
1991: Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Tono T; Nagano H; Kanai T; Mori T
Induction of tolerance to islet allografts with preoperative donor spleen cell injection and a short course of FK 506 treatment.
Transplantation proceedings 1991;23(6):3221-2.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hiroaki Nagano

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Physiology

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hiroaki Nagano (preview)

All Publications